Silo PharmaSILO
13F holders, Q1 2024 (March 31)10holders
$10.81avg. 13F price*
At the end of Q1 2024, 10 institutions reported holding Silo Pharma Inc. (SILO) in their 13F filings. The largest holders were Financial Advocates Investment Management ($122K), Vanguard Group Inc. ($32K) and Geode Capital Management, LLC ($31K).
- Company
- Silo Pharma Inc.
- CUSIP
- 82711P201
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $1.0M |
| Exits | 1 | $18K |
Ownership 10 holders
| Financial Advocates Investment Management | 0.01% | No change | 62,807 | $122K |
| Vanguard Group Inc. | 0.00% | No change | 16,334 | $32K |
| Geode Capital Management, LLC | 0.00% | No change | 16,179 | $31K |
| State Street Corp. | 0.00% | No change | 12,500 | $24K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -36.8% | 4,432 | $9K |
| UBS Group AG | 0.00% | Reduce -98.9% | 374 | $729 |
| Westside Investment Management, Inc. | 0.00% | No change | 94 | $183 |
| FWL Investment Management, LLC | 0.00% | No change | 80 | $156 |
| Wells Fargo & Company | 0.00% | Reduce -15.0% | 17 | $33 |
| JPMorgan Chase & Co. | 0.00% | New | 1 | $2 |
"% of holder's portfolio" is SILO's weight in each manager's 13F, not the share of Silo Pharma Inc. the manager owns.